Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination therapy trials

Alecu I, Milenkova T, Turner SR

Drug Design, Development and Therapy 2018, 12:347-348

Published Date: 21 February 2018